<DOC>
	<DOCNO>NCT02846883</DOCNO>
	<brief_summary>This project determine safety explore effectiveness allogeneic ( cell participant another human ) mesenchymal stromal cell ( MSCs ) decrease inflammation possible enlargement participant ' abdominal aortic aneurysm . Participants select possible subject abdominal aortic aneurysm discover ultrasound compute tomographic ( `` CT '' ) scan request participant ' doctor . The purpose study collect information use determine MSCs use decrease inflammation possibly slow enlargement participant ' aneurysm . The investigator also collect blood sample study special inflammatory cell cause aneurysms well ask participant `` PET '' ( positron emission tomography ) scan measure inflammation directly participant ' aneurysm .</brief_summary>
	<brief_title>Safety Efficacy Allogeneic MSCs Promoting T-regulatory Cells Patients With Small Abdominal Aortic Aneurysms</brief_title>
	<detailed_description>This phase I , double blind trial enroll 36 patient Abdominal Aortic Aneurysms ( AAA ) measure 35-45 mm maximal transverse diameter ( MTD ) . This study ass safety MSCs dose 1 million MSCs/kg . 3 million MSCs/kg . deliver intra-venously . This trial test hypothesis MSCs , dose dependent fashion , promote frequency immune suppressor function CD4+CD25+ FoxP3+ T-regulatory cell decrease AAA inflammation measure 18-fluorodeoxyglucose positron emission tomography/computed tomography ( PET/CT ) . The primary safety endpoint incidence treatment related adverse event accrue 24 month . Efficacy measure change frequency immune suppressor function Tregs , number cytotoxic activity CD4+/CD8+ CD28- T-cells , activate monocyte , change aortic inflammation measure uptake 18-FDG PET/CT compare baseline . Incidence surgical intervention , aneurysm relate death , quality life , major adverse cardiac event record .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<mesh_term>Plasma-lyte 148</mesh_term>
	<criteria>Be 40 80 year age . Have diagnosis noninflammatory degenerative infrarenal abdominal aortic aneurysm measure 3545 mm . diameter Computed Tomography ( CT ) scan . Females childbearing potential must willing use one form birth control duration study . Female participant must undergo blood urine pregnancy test screening . Inflammatory AAA define thicken aortic wall retroperitoneal fibrosis adhesion peritoneal organ , elevate erythrocyte sedimentation rate opinion investigator . Mycotic AAA define saccular morphology , positive blood culture , fever , opinion investigator . Symptomatic , Saccular , AAA associate thoracic aorta dilatation &gt; 5.0 cm . Infrarenal AAA associate Marfan 's EhlersDanlos Syndrome connective tissue disorder . Common external iliac artery aneurysm &gt; 30 mm . maximal transverse diameter . AAA due dissection . Allergy iodine contrast . History cancer within last 5 year , except basal cell skin carcinoma clean border pathology report . eGFR &lt; 30mL/min . Any condition require immunosuppressant medication ( e.g. , treatment organ transplant , psoriasis , Crohn 's disease , alopecia areata , rheumatoid arthritis , scleroderma , lupus ) . Acute coronary syndrome last 30 day prior enrollment . * CHF hospitalization within last 30 day prior enrollment . * HIV HCV positive , active HBV . Contraindication Computed Tomography know allergy contrast medium . Any bleeding diathesis define INR 2.0 ( anticoagulation therapy ) history platelet count le 70,000 hemophilia . Pregnant breast feed woman . Significant hepatic dysfunction ( ALT AST great 2 time normal ) . Life expectancy less two year . Inability provide write informed consent due cognitive language barrier ( interpreter permit ) . Presence clinical condition opinion PI sponsor make patient suitable participate trial . As defined standard definition CHF ACS American Heart Association .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>aneurysm</keyword>
</DOC>